Pharmaceutical manufacturer for Liquid formulation

DPT, a subsidiary of Mylan, is a prominent contract development and manufacturing organization, known for its expertise in semi-solid and liquid forms of medication. Established in 1938, DPT offers top-notch development and manufacturing solutions to our clients. With a workforce of around 1,000 individuals in San Antonio, Texas, DPT possesses unparalleled experience, resources, and capability to effectively cater to the needs of its clients.

Bioplus is a comprehensive partner providing pharmaceutical solutions from start to finish for contract services. They are an integrated Biopharmaceutical, Health, Wellness and Nutrition company, with a strong focus on research and development to create innovative products and formulations globally. Their expertise lies in Finished Dosage Forms & Speciality API’s with emphasis on using green technology production methods. They are ready for Phase 3 manufacturing of New Chemical Entities (NCE) for myopia. Bioplus Life Sciences is a prominent company offering contract research, development, distribution and manufacturing services for licensed and over-the-counter (OTC) pharmaceuticals. Serving a wide range of clients from small businesses to well-known brands across more than 60 countries, Bioplus has numerous manufacturing sites and a workforce of over 2,000 employees. With over 70 years in the industry, Bioplus adheres to strict regulations and provides cutting-edge solutions with advanced technology. They have complete in-house capabilities for product development, manufacturing and distribution of various delivery formats, all compliant with international regulations.

We are a pharmaceutical CDMO established in 2020 through the merger of C.O.C. Farmaceutici and Tubilux Pharma, two thriving Italian enterprises with extensive expertise in this field. We are the foremost company in Italy specializing in the contract development, production, and filling of pharmaceuticals and medical devices for ophthalmic, nasal, respiratory, and topical uses. Our clientele consists of multinational corporations, large conglomerates, as well as small to medium-sized pharmaceutical firms, whether with or without manufacturing facilities. Our products are experiencing increasing demand across Europe, the Middle East, North Africa, and the United States.

We are an international CDMO specialized in soft gel capsules, non-sterile liquid formulations, and R&D offerings. Our expertise lies in contract manufacturing of pharmaceuticals, medical devices, dietary supplements, veterinary products, and beauty products. Our primary focus is on producing soft capsules and non-sterile liquid forms.

Oncomed Manufacturing a.s. operates as a Contract Development and Manufacturing Organization specializing in the manufacturing of potent and anticancer (cytotoxic) injectables at clinical and commercial scale. The company's focus includes small molecule APIs with an end-to-end solution, as well as more innovative large molecule drugs such as ADCs, HPAPI proteins, mAb, and oligonucleotides.

Atral is a pharmaceutical organization dedicated to the production, research, advancement & marketing of proprietary medications and health-related goods in Portugal & in various geographical regions, striving for the development of enduring collaborative partnerships & providing complementary services. Atral operates in 3 key business sectors: Domestic market (selling its own products in Portugal); International market (distribution of own brands and Licensing out) & Contract manufacturing.

Chemineau produces fluid and semi-solid wellness products packaged in tubes, containers, mists, and bag-on-valve systems. Our adaptable and small-scale teams blend proficiency and passion to tackle your industrial and developmental obstacles in pharmaceuticals, OTC, and personal care specialties, regardless of the level of intricacy and advancement. Supported by industrial expertise and cutting-edge machinery, Chemineau possesses the capability to provide a range of adaptable services and production solutions, encompassing pioneering and intricate galenics, highly potent formulas, especially micro & nano dosed emulsions.

Established 35 years ago, JAMP Pharma Group is a privately owned Canadian company that comprises six divisions encompassing all areas of the pharmaceutical sector. Their extensive and varied portfolio consists of over 300 compounds, providing solutions for generics, branded products, specialty medications, vitamins, minerals, supplements, natural health, beauty products, and biosimilar products. The company's commercial activities and sales force presence across all segments of the pharmaceutical market deliver tailored assistance to partners and healthcare professionals throughout Canada. JAMP Pharma, which was founded in 1988, has become one of the rapidly growing generic companies in Canada. Since 2008, its revenues have displayed an annual compound growth rate of 40%. The company proudly ranks among the top five generic companies based on the scale of its portfolio and leads in product launches in the generic pharmaceutical industry in Canada, filling crucial product gaps in the generic market and aiming to offer Canadians more generic alternatives. They invite partnerships for better access to pharmacists in the Canadian market.

One Pharma, a rapidly growing producer of pharmaceutical finished dosages, was founded in Athens in 1991 under the name Pharmanel. It manufactures more than 200 formulations covering various therapeutic areas and serves over 50 clients in 15 different nations. One Pharma undergoes regular audits by the National Organization for Medicines to ensure compliance with European standards, in addition to other regulatory bodies. Its facility adheres to EU-GMP and ISO 9001:2015 criteria. One Pharma gives its clients an advantage in introducing generic products, along with supplementary services that assist them in maintaining competitiveness and profitability throughout the products' lifecycle.